Mediators of Inflammation
Volume 2013, Article ID 751068, 10 pages
http://dx.doi.org/10.1155/2013/751068
Probiotics in the Management of Lung Diseases
1Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands
2Chronic Respiratory Diseases Research Center and National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Department of Immunology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
3Airways Disease Section, National Heart and Lung Institute, Imperial College London, London, UK
4Danone Research Centre for Specialised Nutrition, Wageningen, The Netherlands
Received 1 December 2012; Revised 14 March 2013; Accepted 28 March 2013
Academic Editor: Alex Kleinjan
Copyright © 2013 Esmaeil Mortaz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
How to Cite this Article
Esmaeil Mortaz, Ian M. Adcock, Gert Folkerts, Peter J. Barnes, Arjan Paul Vos, and Johan Garssen, “Probiotics in the Management of Lung Diseases,” Mediators of Inflammation, vol. 2013, Article ID 751068, 10 pages, 2013. https://doi.org/10.1155/2013/751068.